Carderock Capital Management Inc Bristol Myers Squibb CO Transaction History

Carderock Capital Management Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$65.71 - $74.53 $129,777 - $147,196	1,975 New	1,975 $136,000
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $118,254 - $137,856	-2,205 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$59.17 - $69.31 $91,417 - $107,083	-1,545 Reduced 41.2%	2,205 $130,000
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $43,021 - $48,386	-725 Reduced 16.2%	3,750 $237,000
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $1,435 - $1,591	-25 Reduced 0.56%	4,475 $270,000
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $51,530 - $60,244	-940 Reduced 17.28%	4,500 $265,000
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $21,576 - $31,354	465 Added 9.35%	5,440 $303,000
Q4 2019 Feb 04, 2020	SELL	$49.21 - $64.19 $3,690 - $4,814	-75 Reduced 1.49%	4,975 $319,000
Q3 2019 Oct 24, 2019	SELL	$42.77 - $50.71 $8,554 - $10,142	-200 Reduced 3.81%	5,050 $256,000
Q2 2019 Jul 15, 2019	SELL	$44.62 - $49.34 $35,696 - $39,472	-800 Reduced 13.22%	5,250 $238,000
Q1 2019 Apr 23, 2019	SELL	$45.12 - $53.8 $119,568 - $142,570	-2,650 Reduced 30.46%	6,050 $289,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $2,925 - $3,793	-60 Reduced 0.68%	8,700 $452,000
Q2 2018 Jul 16, 2018	BUY	$50.53 - $62.98 $27,033 - $33,694	535 Added 6.5%	8,760 $485,000
Q4 2017 Jan 25, 2018	SELL	$59.94 - $65.35 $26,973 - $29,407	-450 Reduced 5.19%	8,225 $504,000
Q2 2017 Aug 10, 2017	BUY	N/A	8,675	8,675 $483,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Carderock Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Carderock Capital Management Inc with notifications on news.